The Kidney Transplantation Unit of Vall d'Hebron Hospital was the first European center to include patients in the post-authorization efficacy study, the step prior to approval by the European Medicines Agency.

The paper presents the consensus among 16 experts from around the world analyzing the impact of ECMO during the pandemic.

Six Vall d'Hebron researchers have participated in the meeting organized by the Fetal Medicine Foundation.

The research, published in The Lancet, studied patients in Barcelona and Madrid, and shows that direct contact is the main route of transmission for the disease.

The international study in which Vall d'Hebron participated has found that these women may experience a lower health-related quality of life regardless of how long ago the abuse occurred.

His project reports the increased diagnostic power of high-resolution bowel manometry in patients with suspected small bowel motor disorder compared to conventional technology.

A study published in the Journal of Healthcare Quality Research describes the transformation process at the Vall d’Hebron University Hospital in response to the first few months of the COVID-19 pandemic.

The HepClink project, started in 2019, has been effective in reaching an immigrant population with low knowledge of the disease and that, in general, has not been tested before

Es tracta d'un projecte pioner a l'Estat que ha permès detectar més de 128 persones amb el virus actiu, de les quals 40 han estat tractades i curades.

Vall d'Hebron is one of the participants in the CARB-ES-19 research, led by the CIBER, in which 71 hospitals throughout the peninsula have collaborated.

The researcher Carles Rubio presented the research of the VHIR Microbiology research group and the UPC and co-funded by the Probitas Foundation.

Dr. Luz Uria was recognized for the best communication of the Congress of the Sociedad Española de Hematología y Oncología Pediátrica, the second place was for Dr. Raquel Hladun.

The first global study on the prevalence of functional gastrointestinal disorders has been the most successful article.

Es va reconèixer la tasca de més de 70 professionals dedicades a aquesta malaltia pulmonar, tant assistencial com de recerca.

The meeting allows establishing the basis for collaboration between experts from around the world, with the aim of promoting research on this protein and its role in cancer.

In pediatric cancers, sarcomas account for 14% of cases and 20% of deaths.

On the 2nd and 3rd of June, the European University Hospital Alliance (EUHA) celebrated its 5th anniversary with a symposium at University Hospitals Leuven.

Manina Medtech received a direct grant of 75,000 euros from the ACCIÓ Startup Capital line, aimed at boosting the growth of emerging companies with high technological potential.

This award is given to people and organisations in recognition of outstanding contributions to the development of science and technology in Catalonia.

The drug EB1 is able to block resistance pathways to standard cancer treatments and could increase the efficacy of chemotherapy or immunotherapy.

EJP RD announces the release of the Innovation Management Toolbox (IMT), a tool created to provide self-help resources specific to the needs of researchers in this type of pathologies.

The research led by Dr. José Alegre has been one of the 21 projects selected in the 19th call for Health Research Grants.

We present VHIR's annual commitment to communicate the scientific and institutional results of 2021 with a renewed format and design.

Ana Sánchez és investigadora predoctoral del grup Diagnostic Nanotools del VHIR i la seva tesi es centra en l’ús de cèl·lules sintètiques per millorar el control de pandèmies de grip.